20.10.2019, 1098 Zeichen

Marinomed: Investors aws Mittelstandsfonds and Invest AG each have sold 47,500 shares in Marinomed Biotech AG, thus in aggregate 95,000 Marinomed shares, from their holdings to institutional investors by means of an accelerated bookbuilding transaction (the "ABB"). This amounts to 6.5% of Marionomed Biotech AG's share capital. The upsize alternative of up to 45,000 additional Marinomed shares was exercised in an amount of 20,000 additional Marinomed shares. The Marinomed shares were sold for Euro 95.00 each. The total sale proceeds of the ABB for aws Mittelstandsfonds and Invest AG therefore amounts to Euro 10.93 mn. Erste Group Bank AG acted as the sole bookrunner. Following completion of the ABB, aws Mittelstandsfonds and Invest AG each still hold approximately 3.2% of the share capital of Marinomed Biotech AG. For these shares the lock-up commitment of aws Mittelstandsfonds and Invest AG, which was entered into as part of the IPO, continues to apply.
Marinomed Biotech: weekly performance: -0.50%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (16/10/2019)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1191: ATX schliesst bei sehr niedrigem Volumen knapp unter High, der DAX ist auf High, AT&S wieder über 200

Bildnachweis

Aktien auf dem Radar:Polytec Group, AT&S, Kapsch TrafficCom, Austriacard Holdings AG, Semperit, Amag, Rosgix, Agrana, Mayr-Melnhof, Uniqa, Frequentis, EVN, Lenzing, Gurktaler AG Stamm, Gurktaler AG VZ, Marinomed Biotech, Palfinger, Porr, SBO, Strabag, voestalpine, FACC, BKS Bank Stamm, CPI Europe AG, Österreichische Post, Telekom Austria, UBM, Deutsche Boerse, MTU Aero Engines, Zalando, Airbus Group.

---